GlassScriptPhysician profile
Lanaya Danielle Hils
NPI 1366085045
$5,009.50
in general payments reported to CMS, 2019-2025
23 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $385 · 2022: $1,049 · 2023: $1,818 · 2024: $1,534 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,575.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,176.74 | 2021-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Abbvie INC. | $1,098.93 | 2021-2025 | |
| Medtronic, INC. | $950.97 | 2021-2024 | Intellis Adaptivestim, Accurian |
| Collegium Pharmaceutical, INC. | $506.13 | 2022-2024 | Xtampza, Belbuca |
| Vertos Medical, INC. | $464.26 | 2022-2024 | Mild Device Kit |
| Axonics, INC. | $126.45 | 2022-2023 | Axonics |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.89 | 2021-2024 | Relistor |
| Averitas Pharma INC. | $91.25 | 2023-2024 | Qutenza |
| Biohaven Pharmaceuticals, INC. | $68.77 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $54.58 | 2022 | |
| Grt US Holding, INC. | $39.11 | 2022 | |
| Pfizer INC. | $38.59 | 2024 | |
| Amgen INC. | $37.15 | 2021-2022 | |
| Tersera Therapeutics LLC | $35.04 | 2022-2024 | Prialt |
| Saluda Medical Americas, INC. | $34.94 | 2024 | Evoke |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $29.42 | 2022 | |
| Neurelis, INC. | $23.70 | 2025 | Valtoco |
| Amneal Pharmaceuticals LLC | $22.15 | 2023 | Lyvispah |
| Painteq LLC | $18.46 | 2024 | Painteq |
| Ibsa Pharma INC. | $17.63 | 2024 | Licart, Tirosint |
| Relievant Medsystems, INC. | $17.15 | 2021 | |
| Bioventus LLC | $16.79 | 2023 | Durolane |
| Nalu Medical, INC. | $15.40 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lanaya Hils listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.